Professor Armand Bensussan completed his PhD training during the early 1980s in the laboratories of Professor Jean Dausset (Saint-Louis Hospital, Paris, France) and Professor Stuart F Schlossman (Harvard Medical School, DFCI, Boston, MA). He is currently Research director at INSERM and chief of the Skin Research Center and of the INSERM unit 976 at Saint-Louis Hospital in Paris, France. He obtained several awards including two distinct French Academy of Sciences awards, the clinical investigation award from the French foundation for medical research, the immunology Bernard Halpern award and the national award of projects leaders for the creation and/or the development of highly innovative technology companies. He was the past president of the French society of immunology. He is the co-founder of the biotechnology companies Orega Biotech (www.orega-biotech.com) and Alderaan Biotechnolgy (www.adventfb.com). His main scientific contributions have been in the field of basic and clinical immunology and in tumor dermatology. He is author of more than 340 international scientific publications, editor of two scientific books and designated as co-inventor in more than 30 patents, which most of them are licensed to industry. He is a member of the Human Cell Differentiation Molecules council (http://www.hcdm.org) and of the EuroMAbNet council (http://www.euromabnet.com).